Zymeworks (ZYME) Cash from Operations (2021 - 2026)
Zymeworks (ZYME) reported Cash from Operations of 45718000.0 for Q1 2026, down 1241.88% on a YoY basis from 4003732.93 in Q1 2025, and down 345.64% sequentially from 10259000.0 in Q4 2025.
Zymeworks (ZYME) Cash from Operations (2021 - 2026) Analysis & Trends
Zymeworks (ZYME) has 6 years of Cash from Operations data on file, last reported at 45718000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 1241.88% year-over-year to 45718000.0; the trailing twelve-month figure through Mar 2026 stood at 75316000.0 (up 0.63% YoY), and the FY2025 full-year result was 33005000.0, up 70.01% from the prior year.
- Cash from Operations eased to 45718000.0 in Q1 2026, from 10259000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 327360000.0 in Q4 2022 to a low of 83191000.0 in Q1 2023.
- A 5-year average of 9588000.0 and a median of 31412000.0 in 2025 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations jumped 748.12% in 2022 and slumped 1241.88% in 2026, its largest moves.
- Tracing ZYME's Cash from Operations over 5 years: stood at 327360000.0 in 2022, then tumbled by 95.74% to 13933000.0 in 2023, then slumped by 397.93% to 41510000.0 in 2024, then soared by 75.29% to 10259000.0 in 2025, then slumped by 345.64% to 45718000.0 in 2026.
- Business Quant data shows ZYME's Cash from Operations at 45718000.0 in Q1 2026, 10259000.0 in Q4 2025, and 31412000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 201.34 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -354.17 Mn |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - | -45.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.72 Mn |
| Mar 31, 2026 | -45.72 Mn |
| Dec 31, 2025 | -10.26 Mn |
| Dec 31, 2025 | -10.26 Mn |
| Sep 30, 2025 | -31.41 Mn |
| Sep 30, 2025 | -31.41 Mn |
| Jun 30, 2025 | 12.07 Mn |
| Jun 30, 2025 | 12.07 Mn |
| Mar 31, 2025 | -3.41 Mn |
| Mar 31, 2025 | -3.41 Mn |
| Dec 31, 2024 | -41.51 Mn |
| Dec 31, 2024 | -41.51 Mn |
| Sep 30, 2024 | -5.88 Mn |
| Sep 30, 2024 | -5.88 Mn |
| Jun 30, 2024 | -24.99 Mn |
| Jun 30, 2024 | -24.99 Mn |
| Mar 31, 2024 | -37.68 Mn |
| Mar 31, 2024 | -37.68 Mn |
| Dec 31, 2023 | 13.93 Mn |
| Dec 31, 2023 | 13.93 Mn |